Return to search

NexGenix Raises Series B

NexGenix Pharmaceuticals Holdings Inc., a New York-based developer drugs to treat neurofibromatosis and related sporadic tumors, has raised $3.9 million in Series B funding. No investor information was disclosed. www.nexgenixpharm.com